Dome JS - Search Results

1

Association of Chromosome 1q Gain With Inferior Survival in Favorable-Histology Wilms Tumor: A Report From the Children's Oncology Group.

Gratias EJ, Dome JS, Jennings LJ, Chi YY, Tian J, Anderson J, Grundy P, Mullen EA, Geller JI, Fernandez CV, Perlman EJ. Gratias EJ, et al. Among authors: dome js. J Clin Oncol. 2016 Sep 10;34(26):3189-94. doi: 10.1200/JCO.2015.66.1140. Epub 2016 Jul 11. J Clin Oncol. 2016. PMID: 27400937 Free PMC article.

2

High telomerase reverse transcriptase (hTERT) messenger RNA level correlates with tumor recurrence in patients with favorable histology Wilms' tumor.

Dome JS, Chung S, Bergemann T, Umbricht CB, Saji M, Carey LA, Grundy PE, Perlman EJ, Breslow NE, Sukumar S. Dome JS, et al. Cancer Res. 1999 Sep 1;59(17):4301-7. Cancer Res. 1999. PMID: 10485476

3

Improved survival for patients with recurrent Wilms tumor: the experience at St. Jude Children's Research Hospital.

Dome JS, Liu T, Krasin M, Lott L, Shearer P, Daw NC, Billups CA, Wilimas JA. Dome JS, et al. J Pediatr Hematol Oncol. 2002 Mar-Apr;24(3):192-8. doi: 10.1097/00043426-200203000-00007. J Pediatr Hematol Oncol. 2002. PMID: 11990305 Clinical Trial.

4

Management of Wilms' tumour: current practice and future goals.

Kalapurakal JA, Dome JS, Perlman EJ, Malogolowkin M, Haase GM, Grundy P, Coppes MJ. Kalapurakal JA, et al. Among authors: dome js. Lancet Oncol. 2004 Jan;5(1):37-46. doi: 10.1016/s1470-2045(03)01322-6. Lancet Oncol. 2004. PMID: 14700607 Review.

5

Telomerase expression predicts unfavorable outcome in osteosarcoma.

Sanders RP, Drissi R, Billups CA, Daw NC, Valentine MB, Dome JS. Sanders RP, et al. Among authors: dome js. J Clin Oncol. 2004 Sep 15;22(18):3790-7. doi: 10.1200/JCO.2004.03.043. J Clin Oncol. 2004. PMID: 15365076

6

Local lymph node involvement does not predict poor outcome in pediatric renal cell carcinoma.

Geller JI, Dome JS. Geller JI, et al. Among authors: dome js. Cancer. 2004 Oct 1;101(7):1575-83. doi: 10.1002/cncr.20548. Cancer. 2004. PMID: 15378495 Free article.

7

High telomerase RNA expression level is an adverse prognostic factor for favorable-histology Wilms' tumor.

Dome JS, Bockhold CA, Li SM, Baker SD, Green DM, Perlman EJ, Hill DA, Breslow NE. Dome JS, et al. J Clin Oncol. 2005 Dec 20;23(36):9138-45. doi: 10.1200/JCO.2005.00.562. Epub 2005 Sep 19. J Clin Oncol. 2005. PMID: 16172460

8

Rhabdoid tumor of the kidney in the National Wilms' Tumor Study: age at diagnosis as a prognostic factor.

Tomlinson GE, Breslow NE, Dome J, Guthrie KA, Norkool P, Li S, Thomas PR, Perlman E, Beckwith JB, D'Angio GJ, Green DM. Tomlinson GE, et al. J Clin Oncol. 2005 Oct 20;23(30):7641-5. doi: 10.1200/JCO.2004.00.8110. J Clin Oncol. 2005. PMID: 16234525

9

Current therapy for Wilms' tumor.

Metzger ML, Dome JS. Metzger ML, et al. Among authors: dome js. Oncologist. 2005 Nov-Dec;10(10):815-26. doi: 10.1634/theoncologist.10-10-815. Oncologist. 2005. PMID: 16314292 Free article. Review.

10

Adjuvant therapy in pediatric patients with completely resected renal cell carcinoma.

Geller JI, Dome JS. Geller JI, et al. Among authors: dome js. Pediatr Blood Cancer. 2006 Apr;46(4):527. doi: 10.1002/pbc.20571. Pediatr Blood Cancer. 2006. PMID: 16365852 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

193 results

Search Page

Filters